Reported Consolidated quarterly numbers for Divis Laboratories are: Net Sales at Rs 2,604.00 crore in December 2025 up 12.29% ...

Welcome to the Divis Labs Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Management said operational metrics improved during the quarter despite near-term revenue softness and indicated that growth ...

This article first appeared on GuruFocus. Divi's Laboratories Ltd (NSE:DIVISLAB) is set to release its Q3 2026 earnings on Feb 11, 2026. The consensus estimate for Q3 2026 revenue is $25.96 billion, ...

Analysts have tweaked share price targets and future outlook after some of these companies announced their December quarter results.

Divis Laboratories shares opened at ₹6,473.20 against their previous close of ₹6,474.50 and dropped 4% to an intraday low of ...

Jefferies appeared the most bullish on the counter, hiking the target price, while Morgan Stanley reduced the target price, citing a subdued environment in the Generics' business.

On Monday, Nifty 50 closed flat at 24,836.10. The benchmark index however hit an all-time high of 24,999.75. Leading the gains, Divis Laboratories topped the charts with a 2.78% rise in its stock ...

The stock of Divi’s Laboratories (₹6,473.50) has been moving in a long range between ₹5,250 and ₹7,000 in the last one year. Immediate support levels are at ₹6,359 and ₹6,200. Nearest resistances are ...

Reported Standalone quarterly numbers for Divis Laboratories are: Net Sales at Rs 2,578.00 crore in December 2025 up 12.23% ...

Discover the Divis Labs Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock. Keep track of Divis Labs with the latest details, including: Last ...